summary
Introduced
02/20/2025
02/20/2025
In Committee
02/20/2025
02/20/2025
Crossed Over
Passed
Dead
Introduced Session
2025-2026 Regular Session
Bill Summary
Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for prohibited acts and penalties.
AI Summary
This bill amends The Controlled Substance, Drug, Device and Cosmetic Act to establish more severe penalties specifically for offenses involving fentanyl and its analogues. Currently, the law contains general provisions for drug-related violations, but this bill creates a new subsection (f.1) that imposes stricter criminal penalties for knowingly or intentionally violating certain drug-related clauses when fentanyl or fentanyl analogues are involved. Under the new provision, individuals convicted of such offenses could face up to twenty years in prison, a fine of up to $500,000, or both. The bill represents a targeted approach to addressing the ongoing opioid crisis by introducing more significant legal consequences for fentanyl-related drug offenses. The changes will go into effect 60 days after the bill is signed into law, giving law enforcement and the judicial system time to prepare for the new sentencing guidelines.
Committee Categories
Justice
Sponsors (9)
Doyle Heffley (R)*,
Bud Cook (R),
Mark Gillen (R),
Lee James (R),
Andrew Kuzma (R),
Lou Schmitt (R),
Brian Smith (R),
Dane Watro (R),
Dave Zimmerman (R),
Last Action
Referred to Judiciary (on 02/20/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...